Novo CEO pressed by Senate to chop prices of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would think about new talks with insurers with regards to the record costs of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. https://johnnywnduk.ltfblog.com/29865669/not-known-facts-about-healthcare-news